Nanoform says CESS manufacturing undercuts spray-dried ASD costs in industry analysis
Bitget2026/09/22 05:04- Nanoform published an industry analysis positioning its CESS technology as lower-cost than spray-dried amorphous solid dispersions.
- The analysis cites a scale-up factor above 1,000,000, with commercial output in kilograms per hour and multi-ton annual capacity.
- CESS is presented as reducing cost of goods via higher yields, lower capital needs, simplified downstream processing, and less excipient use.
- The report highlights higher drug loading versus ASDs, citing nanoenzalutamide at 40% versus 12% in a marketed ASD benchmark.
- CESS is positioned as more sustainable than spray drying by using recycled pharmaceutical-grade CO2 instead of organic solvents.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Vodafone (VOD.US) Swings to Loss in First Half, German Operations Major Drag
Vodafone (VOD.US) released its financial results for the first half of fiscal year 2027.
AI gamble backfires! Data center project writedowns and weak tech stock positions drag down SoftBank (SFTBY.US) to a Q2 loss of $7.1 billion
SoftBank recorded its first net loss in nearly two years due to a $3.7 billion impairment loss arising from a U.S. data center project, coupled with mounting market concerns over the sustainability of artificial intelligence (AI) growth impacting the investment giant’s key holdings.
AI Cloud Sector Faces a Key Moment: CoreWeave (CRWV.US) Set to Announce Earnings, Wells Fargo Remains Bullish
CoreWeave (CRWV.US) will release its third-quarter financial report after the U.S. stock market closes on Tuesday. This is seen as a key test for the strength of the new AI cloud sector.
JPMorgan raises target prices for Target and Walmart
Crypto prices
More
